← Eichor
Condition: Hemangioma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hemangioma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Uncovering Genes Behind Cartilage Tumors and Vascular Anomalies Using Genomic Sequencing
Phase N/A · 1 location(s) · Eunice Kennedy Shriver National Institute of Child Health an · NCT06749366
The Epithelioid Hemangioendothelioma Registry of the European Reference Network on Rare Adult Solid Cancers (EURACAN)
Phase N/A · 22 location(s) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · NCT06408441
A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in N
NA · 1 location(s) · Massachusetts General Hospital · NCT01873131
A Prospective Study on the Role of Karl Storz Curved and Straight Fetoscopes (11508AAK and 11506AAK) for Fetoscopic Intr
NA · 1 location(s) · Boston Children's Hospital · NCT06056635
Low- vs High-Dose Sirolimus With Prednisolone for KHE and KMP
Phase 2/Phase 3 · 1 location(s) · Yi Ji · NCT07656909
Sonography-guided Resection of Brain Mass Lesions
NA · 1 location(s) · Sklifosovsky Institute of Emergency Care · NCT05484245
Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the
NA · 20 location(s) · Institut Claudius Regaud · NCT03967834
A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors
Phase 1 · 1 location(s) · BridGene Biosciences Inc. · NCT06452160
Intraoperative Brain Shift Calculation Study
NA · 1 location(s) · Sklifosovsky Institute of Emergency Care · NCT05477680
Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy
Phase N/A · 2 location(s) · yuanli Zhao · NCT04076449
Exploration and Evaluation of Amygdalo-Hippocampectomy According to Prof. Coubes' Technique: An Anatomical, Clinical, an
Phase N/A · 1 location(s) · University Hospital, Montpellier · NCT06915649
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and S
Phase 1/Phase 2 · 7 location(s) · St. Jude Children's Research Hospital · NCT06239272
Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma
Phase 2/Phase 3 · 1 location(s) · West China Hospital · NCT06798363
Maximizing Laser Therapy Success for Port-Wine Birthmarks in Pediatric Patients
NA · 2 location(s) · University of Texas Southwestern Medical Center · NCT07183644
Lymphatic Anomalies Registry for the Assessment of Outcome Data
Phase N/A · 1 location(s) · Boston Children's Hospital · NCT02399527
Percutaneous Gelled Alcohol Sclerotherapy for Aggressive Angiomas: Evaluation of Feasibility, Safety, and Efficacy
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire de Saint Etienne · NCT06607731
SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma
Phase 2 · 6 location(s) · Sarcoma Alliance for Research through Collaboration · NCT07104331
Agnostic Therapy in Rare Solid Tumors
Phase 2 · 8 location(s) · Instituto do Cancer do Estado de São Paulo · NCT06638931
Study on Treatment Decision-Making and Prognostic Follow-Up for Untreated Cerebral Cavernous Malformations
Phase N/A · 1 location(s) · Beijing Tiantan Hospital · NCT06214767
68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.
Phase 4 · 1 location(s) · Weill Medical College of Cornell University · NCT04081701
Real-World Effectiveness and Pharmacogenetics of Belzutifan in VHL Syndrome: The BELIEVE-VHL Trial
Phase 2 · 1 location(s) · José Claudio Casali da Rocha · NCT07167329
Fluctuational Imaging for the Diagnosis of Hepatic Hemangioma: A Multicenter, Prospective Study
Phase N/A · 1 location(s) · Yonsei University · NCT07418294
Propranolol and Von Hippel-Lindau Disease
NA · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05424016
Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 202
Phase N/A · 42 location(s) · European Organisation for Research and Treatment of Cancer - · NCT05259605
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.